ES417157A1 - Procedimiento para obtener y aislar cepas dominantes a par-tir de una cepa de virus de gripe. - Google Patents

Procedimiento para obtener y aislar cepas dominantes a par-tir de una cepa de virus de gripe.

Info

Publication number
ES417157A1
ES417157A1 ES417157A ES417157A ES417157A1 ES 417157 A1 ES417157 A1 ES 417157A1 ES 417157 A ES417157 A ES 417157A ES 417157 A ES417157 A ES 417157A ES 417157 A1 ES417157 A1 ES 417157A1
Authority
ES
Spain
Prior art keywords
cultures
virus
mutants
strains
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES417157A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Publication of ES417157A1 publication Critical patent/ES417157A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES417157A 1972-07-21 1973-07-21 Procedimiento para obtener y aislar cepas dominantes a par-tir de una cepa de virus de gripe. Expired ES417157A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7226337A FR2201876B1 (enExample) 1972-07-21 1972-07-21

Publications (1)

Publication Number Publication Date
ES417157A1 true ES417157A1 (es) 1976-03-01

Family

ID=9102179

Family Applications (1)

Application Number Title Priority Date Filing Date
ES417157A Expired ES417157A1 (es) 1972-07-21 1973-07-21 Procedimiento para obtener y aislar cepas dominantes a par-tir de una cepa de virus de gripe.

Country Status (12)

Country Link
JP (1) JPS4980229A (enExample)
BE (1) BE802649A (enExample)
CA (1) CA1030872A (enExample)
CH (1) CH613229A5 (enExample)
DD (1) DD107719A5 (enExample)
DE (1) DE2337134A1 (enExample)
ES (1) ES417157A1 (enExample)
FR (1) FR2201876B1 (enExample)
GB (1) GB1443958A (enExample)
IL (1) IL42749A0 (enExample)
NL (1) NL7310127A (enExample)
ZA (1) ZA734817B (enExample)

Also Published As

Publication number Publication date
AU5817173A (en) 1975-01-23
FR2201876B1 (enExample) 1975-11-28
NL7310127A (enExample) 1974-01-23
FR2201876A1 (enExample) 1974-05-03
BE802649A (fr) 1974-01-21
GB1443958A (en) 1976-07-28
JPS4980229A (enExample) 1974-08-02
ZA734817B (en) 1974-06-26
CH613229A5 (en) 1979-09-14
CA1030872A (en) 1978-05-09
IL42749A0 (en) 1973-10-25
DE2337134A1 (de) 1974-02-14
DD107719A5 (enExample) 1974-08-12

Similar Documents

Publication Publication Date Title
Kilbourne et al. Antiviral activity of antiserum specific for an influenza virus neuraminidase
Miyahira et al. Quantification of antigen specific CD8+ T cells using an ELISPOT assay
Henle et al. The demonstration of one-step growth curves of influenza viruses through the blocking effect of irradiated virus on further infection
Rowe et al. Additional serotypes of the APC virus group
Carp et al. A comparison of the replication cycles of simian virus 40 in human diploid and African green monkey kidney cells
Rziha et al. BK virus: I. Seroepidemiologic studies and serologic response to viral infection
McMillen et al. Immunological reactivity of antisera to sodium dodecyl sulfate-derived polypeptides of polyoma virions
Horowitz et al. A genetic study of two new structural forms of tyrosinase in Neurospora
Rabinowitz et al. The formation of variants with a reversion of properties of transformed cells: IV. Loss of detectable polyoma transplantation antigen
ES417157A1 (es) Procedimiento para obtener y aislar cepas dominantes a par-tir de una cepa de virus de gripe.
EP0157528A2 (en) Attenuated smallpox vaccine strain
ES430415A1 (es) Un procedimiento para preparar una vacuna de virus de la gripe atenuado.
GB1486186A (en) Vaccines against feline leukaemia and the group of diseases associated with feline leukaemis/virus infection
ES449941A1 (es) Un metodo de preparacion de un nuevo virus vivo de la rabia.
IE40221L (en) Influenza vaccines
CN107603957B (zh) 一种高效扩增j亚群禽白血病病毒的方法
Burnet et al. Study of a strain of influenza B virus isolated by chick-embryo inoculation.
Burnet et al. Reversion to virulence in an influenza virus mutant.
Cairns The limited growth of influenza viruses in the mouse brain.
NO142024C (no) Fremgangsmaate for fremstilling av en vaksine, saerlig influensavaksine, ved aa dyrke et virus
SU639941A1 (ru) Способ обнаружени вируса гриппа
Kern et al. Identification of enteroviruses by hemagglutination-inhibition
Ledinko An analysis of the process of adaptation of influenza virus B of recent human origin to the mouse lung
Otsuki et al. Antigenic variation of avian infectious bronchitis virus during replication in BHK-21 cells
Rhim et al. Rat Embryo Cells in Complement Fixation Tests for Murine Leukaemia Virus